N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia,
Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, Moscow, Russian Federation.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2022 Jul;30(4):683-691. doi: 10.32687/0869-866X-2022-30-4-683-691.
The researchers, in series of articles, analyze significance of the default of 1998 for both pharmaceutical industry and participants of pharmaceutical market. The Report I presents results of investigation of corresponding economic and social aspects of issue. The article presents contradictions in tax and financial policies of then ruling authorities; regulatory drawbacks created by inefficient awareness of economic situation and social specificity of pharmaceutics; means for pharmaceutical companies to survive in these conditions.
研究人员在一系列文章中分析了 1998 年违约对制药行业和制药市场参与者的意义。报告 I 呈现了对相应经济和社会问题方面的调查结果。本文揭示了当时执政当局税收和财政政策之间的矛盾；监管缺陷是由低效的经济形势意识和制药业的社会特殊性造成的；制药公司在这些条件下生存的手段。
